Basilea licenses late-stage oncology drug candidate derazantinib from ArQule

NEXT STORY
Global Point of Care (POC) Infectious Disease Diagnostic Testing Market Report 2018: Focus on Influenza, STD, HIV, Hepatitis, Malaria, C. difficile, E. coli, H. pylori & Home Test/OTC
PREV STORY
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aduro Presents Preclinical Data for Anti-APRIL Antibody BION-1301 for the Treatment of IgA Nephropathy at ASN Kidney Week 2018

BERKELEY, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today ...

author_avatar
NASDAQ Market News

Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.

New Role as the President involves leadership of the entire product portfolioPromotion reflects progress ...

author_avatar
NASDAQ Market News

Ecofriendly Trend a Boon for Edible Packaging Market, says TMR

Edible Packaging Market (Material Type - Polysaccharides Lipid, Surfactant, Protein Films, and Composite Films; ...

author_avatar
NASDAQ Market News